Back
Nektar Therapeutics 10K Form
Buy
62
NKTR
Nektar Therapeutics
Last Price:
1.64
Seasonality Move:
-2.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2023-08-09 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2023-05-10 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2022-11-04 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2022-08-05 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2022-05-06 | 10Q | NKTR/Nektar Therapeutics Quarterly |
Receive NKTR News And Ratings
See the #1 stock for the next 7 days that we like better than NKTR
NKTR Financial Statistics
Sales & Book Value
| Annual Sales: | $90.12M |
|---|---|
| Cash Flow: | $-47.28M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.68 |
| Price / Book: | 2.31 |
Profitability
| EPS (TTM): | -1.46000 |
|---|---|
| Net Income (TTM): | $-276.06M |
| Gross Margin: | $56.35M |
| Return on Equity: | -126.07% |
| Return on Assets: | -52.95% |
Nektar Therapeutics Earnings Forecast
Key Nektar Therapeutics Financial Ratios
- The Gross Profit Margin over the past 30 years for NKTR is 62.53%.
- The Selling, General & Administrative Expenses for NKTR have been equal to 85.90% of Gross Profit Margin.
- The Research & Development expenses have been 126.67% of Revenue.
- The Interest Expense is -9.18% of Operating Income.
- The Net Earning history of NKTR is -306.31% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 14 years.
Nektar Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NKTR |
| CUSIP: | 640268 |
| Website: | nektar.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.45 |
| Quick Ratio: | 5.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NKTR Technical Analysis vs Fundamental Analysis
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a Buy
The current Nektar Therapeutics [NKTR] share price is $1.65. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.